JP2013517273A5 - - Google Patents

Download PDF

Info

Publication number
JP2013517273A5
JP2013517273A5 JP2012549000A JP2012549000A JP2013517273A5 JP 2013517273 A5 JP2013517273 A5 JP 2013517273A5 JP 2012549000 A JP2012549000 A JP 2012549000A JP 2012549000 A JP2012549000 A JP 2012549000A JP 2013517273 A5 JP2013517273 A5 JP 2013517273A5
Authority
JP
Japan
Prior art keywords
amino
methyl
pyrimidinyl
benzenesulfonamide
ylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012549000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013517273A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/020798 external-priority patent/WO2011088027A1/en
Publication of JP2013517273A publication Critical patent/JP2013517273A/ja
Publication of JP2013517273A5 publication Critical patent/JP2013517273A5/ja
Pending legal-status Critical Current

Links

JP2012549000A 2010-01-13 2011-01-11 化合物および方法 Pending JP2013517273A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29463710P 2010-01-13 2010-01-13
US61/294,637 2010-01-13
PCT/US2011/020798 WO2011088027A1 (en) 2010-01-13 2011-01-11 Compounds and methods

Publications (2)

Publication Number Publication Date
JP2013517273A JP2013517273A (ja) 2013-05-16
JP2013517273A5 true JP2013517273A5 (enExample) 2014-02-20

Family

ID=44304601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012549000A Pending JP2013517273A (ja) 2010-01-13 2011-01-11 化合物および方法

Country Status (13)

Country Link
US (1) US20120329784A1 (enExample)
EP (1) EP2523559A4 (enExample)
JP (1) JP2013517273A (enExample)
KR (1) KR20120114355A (enExample)
CN (1) CN102791131A (enExample)
AU (1) AU2011205485B2 (enExample)
BR (1) BR112012017277A2 (enExample)
CA (1) CA2786999A1 (enExample)
EA (1) EA201290642A1 (enExample)
IL (1) IL220812A0 (enExample)
MX (1) MX2012008141A (enExample)
SG (1) SG182351A1 (enExample)
WO (1) WO2011088027A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013164323A1 (en) * 2012-05-03 2013-11-07 F. Hoffmann-La Roche Ag Pyrazole aminopyrimidine derivatives as lrrk2 modulators for use in the treatment of parkinson's disease
CN105102448B (zh) 2013-02-28 2018-03-06 百时美施贵宝公司 作为rock1和rock2抑制剂的苯基吡唑衍生物
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
KR102230461B1 (ko) * 2013-03-15 2021-03-22 유니버시티 오브 써던 캘리포니아 엔지오텐신-관련 질환들의 치료를 위한 방법들, 화합물들 및 조성물들
MA41179A (fr) 2014-12-19 2017-10-24 Cancer Research Tech Ltd Composés inhibiteurs de parg
CN104844526B (zh) * 2015-04-16 2018-08-31 温州医科大学 一种4,6-嘧啶二胺类化合物及其制备方法和应用
CN106008366A (zh) * 2016-05-25 2016-10-12 山东大学 一种利匹韦林的制备方法
JP6165373B1 (ja) * 2017-02-24 2017-07-19 タマ化学工業株式会社 ピリジン−3−スルホニルクロリドの製造方法
ES2975690T3 (es) 2017-05-26 2024-07-11 Cancer Research Tech Ltd Inhibidores de BCL6 derivados de benzimidazolona
ES2939776T3 (es) 2018-04-13 2023-04-26 Cancer Research Tech Ltd Inhibidores de BCL6
CN108864052A (zh) * 2018-06-07 2018-11-23 福建医科大学 一种针对gc33-3-1抗体具有特异性识别的荧光探针的合成以及应用
EP4206196A1 (en) * 2021-12-29 2023-07-05 Almirall S.A. Pyrimidine substituted derivatives as tyk2 inhibitors
US20250177391A1 (en) * 2022-02-23 2025-06-05 President And Fellows Of Harvard College Inhibitors of ddr1 and ddr2 for the treatment of arthritis
TW202345809A (zh) 2022-03-23 2023-12-01 美商愛德亞生物科學公司 作為parg抑制劑之經哌取代的吲唑化合物
US11891362B1 (en) * 2023-04-14 2024-02-06 King Faisal University N2,N4-disubstituted pyrimidine-2,4-diamine compounds as antibacterial agents
WO2024243304A2 (en) * 2023-05-23 2024-11-28 Quantx Biosciences Us, Inc. Bicyclic heteroaryl compounds
WO2024249831A2 (en) * 2023-06-02 2024-12-05 Unogen Biotech Ltd. Triple kinase inhibitors
WO2024250010A2 (en) * 2023-06-02 2024-12-05 Atomwise Inc. Inhibitors of tyk2
WO2025096550A1 (en) * 2023-10-31 2025-05-08 Twine Therapeutics, Inc. Methods of treating cardiomyopathy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives
WO2003002544A1 (en) * 2001-06-26 2003-01-09 Bristol-Myers Squibb Company N-heterocyclic inhibitors of tnf-alpha expression
WO2004087707A1 (en) * 2003-03-31 2004-10-14 Vernalis (Cambridge) Limited Pyrazolopyrimidine compounds and their use in medicine
WO2005026129A1 (en) * 2003-09-15 2005-03-24 Gpc Biotech Ag Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
CN1910159A (zh) * 2004-01-16 2007-02-07 诺瓦提斯公司 2,4-二氨基嘧啶和它们用于诱导心肌发生的用途
US20080242681A1 (en) * 2004-01-22 2008-10-02 Altana Pharma Ag N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
US20070203161A1 (en) * 2006-02-24 2007-08-30 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
CA2628283C (en) * 2005-11-01 2017-06-27 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
UA109412C2 (uk) * 2005-11-01 2015-08-25 5-метил-n2-[4-(4-метилпіперазин-1-іл)феніл]-піримідин-2,4-діамін та його застосування в способі одержання сполуки
JP2009540013A (ja) * 2006-06-15 2009-11-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 2−アニリノ−4−(複素環)アミノ−ピリミジン
CN101589036A (zh) * 2006-12-19 2009-11-25 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的氨基嘧啶
WO2008118822A1 (en) * 2007-03-23 2008-10-02 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
EP2014657A1 (de) * 2007-06-21 2009-01-14 Bayer Schering Pharma Aktiengesellschaft Diaminopyrimidine als Modulatoren des EP2-Rezeptors
AU2008314632B2 (en) * 2007-10-19 2015-05-28 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2013517273A5 (enExample)
JP5555169B2 (ja) 電位開口型ナトリウムチャネルの阻害剤として有用なヘテロアリールアミド
RU2312860C2 (ru) Циклические ингибиторы протеинтирозинкиназ
RU2454405C2 (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
JP2013517283A5 (enExample)
ES2610158T3 (es) Nuevos inhibidores pirrólicos de S-nitrosoglutatión reductasa como agentes terapéuticos
US20120329784A1 (en) Compounds and methods
RU2386630C2 (ru) Соединения и композиции в качестве ингибиторов протеинтирозинкиназы
JP2014511869A5 (enExample)
CA2582029A1 (en) Aryl nitrogen-containing bicyclic compounds and methods of use
RU2007100136A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
NZ597528A (en) Inhibitors of flaviviridae viruses
PT1725544E (pt) 3-[4-heterociclil-1,2,3-triazol-1-il]-n-aril-benzamidas como inibidores da produção de citocinas para o tratamento de doenças inflamatórias crónicas
CA2564355A1 (en) Protein kinase modulators and method of use
ZA200606880B (en) Diaminopyrimidines as P2X3 and P2X2/3 antagonists
ZA200505184B (en) Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
JP2007519754A5 (enExample)
JP2013519733A5 (enExample)
JP2004517925A5 (enExample)
JP2010513444A5 (enExample)
JP2003534336A5 (enExample)
CA2494695A1 (en) 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
CN102076671A (zh) 三唑衍生物或其盐
HRP20100283T1 (hr) Derivati n-'(1,5-difenil-1h-pirazol-3-il)sulfonamida s afinitetom za cb1 receptor
JP2008545686A5 (enExample)